Skip to main content
. 2021 Aug 27;23(8):e28695. doi: 10.2196/28695

Figure 2.

Figure 2

Weekly trends in walk steps recorded automatically by the application for 8 weeks (N=33): all patients (A), patient groups according to age (B), pre-RT sarcopenia (C), and excessive muscle loss (-ΔSMI/50 days >10%), during neoadjuvant concurrent chemoradiotherapy. RT: radiotherapy; SMI: skeletal muscle index.